LY-3463251

N/A

Report date: 2023/01/13 14:53:15

Base Information

Drug NameLY-3463251
Drug Alias NameLY-3463251
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionGrowth/differentiation factor 15 agonistsGDNF family receptor alpha-like agonistsTyrosine-protein kinase receptor RET agonists
TargetsGrowth/differentiation factor 15Tyrosine-protein kinase receptor RETGDNF family receptor alpha-like
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEli Lilly And Company
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A